Friday 6 November 2026 Export IMNM’s income statement to Excel — free account

Immunome, Inc.

IMNM Healthcare Biotechnology

Immunome, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.9 million, down 23.2% from fiscal 2024.

Revenue: +69.8%
EPS: −30.0%
Free cash flow: −27.0%

Quarter to June 2026, against a year earlier

Insider buying

18.58 0.67 +3.74%

Follow IMNM

Alert me

Market cap: $2.1B
P/E: 0.0×
Fwd P/E: −7.6×
Dividend yield: —
F-score: 4/9
Altman Z: 21.57
Beneish M: n/a
Dividend safety: n/a

Overview

Immunome, Inc. (IMNM) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Immunome, Inc. (IMNM) trades at a P/B ratio of 3.9×. Over the past ten years it has ranged from 0.0× (December 2020) to 21.5× (December 2023); the current reading is higher than 66% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/IMNM/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Immunome, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/IMNM/metrics/pb-ratio">Immunome, Inc. (IMNM) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	3.0×	(13.95%)
FY2024	3.4×	88.61%
FY2023	1.8×	—

Period	P/B ratio	Change
Jun 2025	3.0×	72.70%
Mar 2025	1.7×	(49.38%)
Dec 2024	3.4×	(16.07%)
Sep 2024	4.1×	42.18%
6 more quarters	Free account

Against its own ten years

Low 0.0× High 21.5×

Ten-year median 3.3×

Current reading's percentile 64

Company	P/B ratio
BHVN Biohaven Ltd. compare	n/m
LKFT Lakefront Biotherapeutics - Sponsored ADR compare	0.6×
CLDX Celldex Therapeutics, Inc. compare	3.1×
AUPH Aurinia Pharmaceuticals Inc compare	3.3×
IMNM Immunome, Inc.	3.9×
VERA Vera Therapeutics, Inc. compare	5.3×
ADMA ADMA Biologics Inc compare	6.7×
VCEL Vericel Corporation compare	6.8×
PVLA Palvella Therapeutics, Inc. compare	10.4×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Immunome, Inc. (IMNM) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on IMNM

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on IMNM

Stockrow Weekly